References
- Our World in Data. Coronavirus Pandemic (COVID-19). Available online: https://ourworldindata.org/coronavirus#coronavirus-country-profiles. [ Last accessed on 2022 Feb 6
- Our World in Data. Share of people vaccinated against COVID-19, February 5, 2022. Available online: https://ourworldindata.org/covid-accinations?country=OWID_WRL [ Last accessed on 2022 Feb 6
- Omicron Wave Shatters Israel’s Daily Infection Record. Available online: https://www.haaretz.com/israel-news/omicron-wave-shatters-israel-s-daily-infection-record-1.10515686 [ Last accessed on 2022 Feb 6
- International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health and World Health Organization. Results of COVID-19 Vaccine effectiveness Studies: An Ongoing Systematic Review: Forest Plots. Available online: https://view-hub.org/sites/default/files/2021-11/COVID19%20VE%20Studies_Forest%20Plots.pdf. [ Last accessedon 2022 Apr 8
- van Doremalen N, Lambe T, Spencer A, et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature 2020;586(7830):58–578.
- Thomas SJ, Moreira ED, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761–1773.
- Baum U, Poukka E, Leino T, et al. High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron. MedRxiv. 2022. DOI:10.1101/2022.03.11.22272140.
- UK Health Security Agency. COVID-19 vaccine surveillance report Week 15: 14 April 2022. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1069256/Vaccine_surveillance_report_-_week_15.pdf [ Last accessed on 2022 Apr 22
- Atmar RL, Lyke KE, Deming ME, et al. Heterologous SARS-CoV-2 booster vaccinations – preliminary report. medRxiv 2021. DOI:10.1101/2021.10.10.21264827.
- Falsey AR, Frenck RW, Walsh EE, et al. SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3. N Engl J Med. 2021;385(17):1627,1629.
- Choi A, Koch M, Wu K, et al. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis. Nat Med. 2021;7(11):2025–2031.
- UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 33. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043807/technical-briefing-33.pdf [ Last accessed on 2022 Apr 24
- World health Organization. Interim statement on booster doses for COVID-19 vaccination. https://www.who.int/news/item/22-12-2021-interim-statement-on-booster-doses-for-covid-19-vaccination—update-22-december-2021. [ Last accessed on 2022 Feb 6
- Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28(4):831–837.
- Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393–1400.
- Patalon T, Gazit S, Pitzer VE, et al. Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine. JAMA Intern Med. 2022;182(2):179–184.
- Kuhlmann C, Mayer CK, Claassen M, et al. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose. Lancet. 2022;399(10325):S0140-6736(22)00090–3.
- Watson C. Three, four or more: what’s the magic number for booster shots? Nature. 2022;602(7895):17–18.
- Roltgen K, Nielson SCA, Silva O, et al. Immune imprinting, breadth of variant recognition and germinal centre response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185(6):1025–1040.e14.
- Vashishtha VM. Is ‘original antigenic sin’ complicating Indian vaccination drive against Covid-19? Hum Vaccin Immunother. 2021;17(10):3314–3315.
- Gagne M, Moliva JI, Foulds KE, et al. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron. Cell. 2022 Mar 25: S0092-8674(22)00388-9. S0092-8674(22)00388-9. 185 9 1556–1571.e18
- Corbett KS, Gagne M, Wagner DA, et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science 2021;374(6573):1343–1353.
- Lowe D Omicron Boosters and Original Antigenic Sin. Science, 2022. Available online: https://www.science.org/content/blog-post/omicron-boosters-and-original-ntigenic-sin. [ Last accessed on 2022 Feb 8
- Tartof SY, Slezak JM, Puzniak L, et al. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study. Lancet Respir Med, Published: 2022 Apr 22. DOI:10.1016/S2213-2600(22)00101-1
- Leonardi AJ, Proenca RB Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19. Front Immunol. 2020 Dec 21;11:600405. PMID: 33408715; PMCID: PMC7779612.
- Leonardi AJ, Argyropoulos CP, Hamdy A, et al. Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation. Front Immunol. 2022;13:853606.
- Alu A, Chen L, Lei H, et al. Intranasal COVID-19 vaccines: from bench to bed. EBioMedicine. 2022;76:103841.
- Mao T, Israelow B, Suberi A, et al. Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses. bioRxiv. 2022. DOI:10.1101/2022.01.24.477597.
- Ying B, Scheaffer SM, Whitener B, et al. Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice. bioRxiv. 2022. DOI:10.1101/2022.02.07.479419.
- Chalkias S, Eder F, Essink B, et al. Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine. Preprint (Research Square) 2022. DOI: 10.21203/rs.3.rs-555201/v1
- Vashishtha VM, Kumar P. Looking to the future: is a universal coronavirus vaccine feasible? Expert Rev Vaccines. 2021Dec30;1–4. doi:10.1080/14760584.2022.2020107 Epub ahead of print. PMID: 34968153